Health Anticoagulation Market to Touch USD 61.49 Billion by 2030 owing to Increasing… Eli Pacheco Apr 4, 2023 0 <!-- Name:DistributionId Value:8800862 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Health Trial Suggests Anticoagulation ‘Sweet Spot’ for COVID in the ICU Eli Pacheco Mar 23, 2023 0 No anticoagulation strategy came out a clear winner for hard outcomes in a hypoxic and…
Health Full-Dose Anticoagulation Again Favored for COVID Admissions Eli Pacheco Mar 8, 2023 0 NEW ORLEANS -- Full-dose anticoagulation failed to improve overall hard outcomes for non-intensive care unit (ICU) admissions…
Health Does All Afib Detected After Stroke Really Have to Trigger Oral Anticoagulation? Eli Pacheco Feb 11, 2023 0 DALLAS -- Neurologists couldn't agree that stroke survivors with a small burden of atrial fibrillation (Afib) could get away…
Health Anticoagulation Again Flops for Outpatient COVID-19 Eli Pacheco Nov 8, 2022 0 CHICAGO -- For outpatient COVID-19, prophylactic anticoagulation with rivaroxaban (Xarelto) did not improve outcomes in…
Health Brief Anticoagulation Preserves Radial Artery After Catheter Access Eli Pacheco Sep 21, 2022 0 BOSTON -- A short course of rivaroxaban (Xarelto) after transradial coronary procedures helped prevent radial artery occlusion…
Health Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19 Eli Pacheco Sep 17, 2022 0 Physician’s Briefing Staff FRIDAY, Sept. 16, 2022 (HealthDay News) -- Full-dose anticoagulation reduces thrombotic complications in critically ill…
Health Full-Dose Anticoagulation Cuts VTE in Severe COVID-19 Eli Pacheco Sep 1, 2022 0 BARCELONA -- Full-dose anticoagulation prevented thromboembolic events in critically ill COVID-19 patients in the COVID-PACT trial.…
Health Standard Anticoagulation May Be Overkill for Pediatric VTE Eli Pacheco Jan 11, 2022 0 For children being treated for a provoked venous thromboembolism (VTE), a shortened course of…
Health Clinical Challenges: Back to Square One in Anticoagulation for PCI? Eli Pacheco Dec 3, 2021 0 Heparin remains the anticoagulant of choice in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS).…